You’ve likely heard stories or read headlines highlighting the potential medical benefits of marijuana, some of which the most promising was managing seizures. And while many hoped that would be true, new research is now pointing in the opposite direction.
A landmark study published in the peer-reviewed medical journal Epilepsia by researchers at Washington University School of Medicine in St. Louis uncovers a concerning reality. Adults with hard-to-treat epilepsy who used recreational cannabis almost every day actually had more than double the number of severe convulsive seizures each year compared to nonusers. Even worse, their seizure medications stopped working 13 years faster.
While regulated, pharmaceutical-grade cannabis compounds have legitimate clinical uses, this observational study highlights a massive gap between prescription treatments and high-potency recreational marijuana. Understanding what the data actually shows and what it means for everyday cannabis consumers and their loved ones is vital for protecting brain health.
The Broader Context: Epilepsy and Cannabis Use Today
To understand why these findings matter, it helps to look at how widespread both epilepsy and cannabis use have become in the United States:
- Epilepsy Prevalence: According to the Centers for Disease Control and Prevention (CDC), approximately 2.9 million U.S. adults (about 1.1% of the adult population) live with active epilepsy. Globally, the World Health Organization (WHO) estimates that over 50 million people have epilepsy, making it one of the most common chronic neurological diseases worldwide.
- Drug-Resistant Epilepsy: The Epilepsy Foundation notes that roughly 1 in 3 people with epilepsy have “drug-resistant” or “refractory” epilepsy, meaning standard antiseizure medications fail to bring their seizures under control.
- Rising Cannabis Use: Data from the Substance Abuse and Mental Health Services Administration (SAMHSA) national surveys show that over 60 million Americans aged 12 and older (more than 21% of the population) use cannabis annually, reflecting rapid growth in recreational consumption across legalized states.
With millions of Americans consuming cannabis while living with neurological conditions, evaluating how frequent cannabis use impacts seizure control is a critical public health priority.
What the Research Discovered
The research project was led by senior author Dr. Aaron F. Struck, an associate professor of neurology at WashU Medicine and Endowed Chair in Epilepsy at Barnes-Jewish Hospital, alongside first author Dr. Santiago Philibert-Rosas. The project was born directly out of real-world clinical observations. Dr. Struck began noticing a pattern in his neurology practice: patients presenting with unusually severe epilepsy who lacked traditional underlying risk factors for complex seizure disorders. The common denominator among them was frequent, high-potency cannabis use.
To investigate this trend, the research team analyzed medical records from 64 adult patients treated between 2019 and 2024 at an inpatient Epilepsy Monitoring Unit at the University of Wisconsin School of Medicine and Public Health.
An Epilepsy Monitoring Unit is a specialized hospital setting where medical teams evaluate patients around the clock using continuous EEG brain wave monitoring and video tracking. Admission to this unit means a patient has drug-resistant epilepsy—a medical benchmark defined as failing to achieve sustained seizure freedom after trying at least two properly chosen and tolerated prescription antiseizure medications.
When researchers compared 22 frequent recreational cannabis users (defined as using cannabis 20 or more days per month) against 42 nonusers, stark differences emerged across several key metrics:
- More Than Double the Seizures: Near-daily cannabis users averaged over twice as many convulsive seizures per year compared to nonusers.
- 90% Experienced Severe Seizures: A full 90% of frequent users suffered generalized tonic-clonic seizures (commonly called grand mal or convulsive seizures). These full-body events involve loss of consciousness and violent muscle shaking, carrying the highest risk for physical injury and Sudden Unexpected Death in Epilepsy (SUDEP). In contrast, about half of the nonusers in the study did not experience these severe convulsive types.
- Meds Stopped Working 13 Years Sooner: Frequent cannabis users ended up needing admission to the specialized monitoring unit after an average of just 5 years from their very first seizure because their prescription drugs failed. Nonusers took an average of 18 years to reach that same stage of drug resistance.
- Younger Demographic Profile: Dr. Philibert-Rosas noted that frequent users presented with a distinct clinical profile: patients predominantly in their 20s, mostly male, and lacking typical structural brain abnormalities or family histories that usually explain early-onset, drug-resistant seizures.
- Discharged on More Medications: Despite having lived with epilepsy for far fewer years, frequent cannabis users required a higher number of daily prescription antiseizure drugs upon hospital discharge than nonusers.
Crucially, among 15 frequent users whose complete timelines could be verified, every single individual began using cannabis before experiencing their first seizure. This detail rules out the idea that patients were simply picking up cannabis as a self-medication strategy to cope with pre-existing, worsening seizures.
The Hidden Mystery in Brain Scans
When doctors evaluate severe, long-standing epilepsy, high-resolution brain scans (MRIs) typically show visible physical scarring on the hippocampus, a deep, seahorse-shaped brain structure crucial for memory formation where many seizures originate.
Surprisingly, the brain scans of the frequent cannabis users in this study looked largely normal. They lacked the expected physical scarring typical of such severe seizure activity.
Dr. Struck explained that because cannabinoid receptors are heavily concentrated in the hippocampus, heavy exposure to high-potency cannabis likely disrupts how brain circuits fire on a functional level rather than causing macroscopic physical tissue damage. Instead of destroying brain tissue, chronic high-dose cannabis exposure appears to disrupt the delicate electrical balance that keeps brain signals firing smoothly.
Why CBD and THC Are Not the Same Thing
Much of the public confusion surrounding cannabis and brain health comes down to mixing up two completely different chemical compounds in the plant: CBD (cannabidiol) and THC (tetrahydrocannabinol).
- CBD (Cannabidiol): Non-psychoactive and non-intoxicating. According to the U.S. Food and Drug Administration (FDA), a highly purified, prescription-only CBD formulation (Epidiolex) is approved to treat specific rare, severe childhood epilepsies (such as Dravet syndrome, Lennox-Gastaut syndrome, and Tuberous Sclerosis Complex). In rigorous clinical trials, pure CBD has demonstrated clear anticonvulsant properties that help suppress seizure activity.
- THC (Tetrahydrocannabinol): The primary psychoactive compound responsible for the high. Preclinical and animal studies indicate that high doses of THC can do the exact opposite of CBD: it can lower the brain’s seizure threshold, making abnormal electrical spikes and seizures more likely to occur.
The inspiring medical news stories that sparked public interest in cannabis focused almost exclusively on high-CBD medical formulations. However, the recreational cannabis sold in dispensaries today is bred specifically for high THC potency, often containing minimal to no CBD. Furthermore, consumers often inadvertently ingest unpredictable doses through unregulated edible dosing and high THC potency, flooding brain receptors with a chemical compound that can destabilize electrical signaling rather than calm it.
What This Means for Everyday Cannabis Consumers
You don’t have to be diagnosed with epilepsy for these findings to matter. If you smoke, vape, use dab carts, or take high-dose edibles regularly, or if you have friends and family who do, this research provides essential context about how heavy cannabis use impacts brain function.
High-THC Products Alter Brain Circuitry
While consuming cannabis occasionally won’t automatically give an otherwise healthy person epilepsy, flooding the central nervous system with high-potency THC lowers the brain’s natural resistance to abnormal electrical activity. For individuals with an undiagnosed genetic vulnerability, a low natural seizure threshold, a history of concussions, or a family history of neurological issues, heavy cannabis use can act like an unforeseen trigger.
Modern Concentrates Carry Higher Potency Risks
The recreational cannabis market has evolved dramatically over recent decades. Concentrates, dab pens, vape cartridges, and high-dose edibles deliver THC concentrations exponentially higher than traditional flower from years past. Consuming these high-potency products near-daily places continuous stress on the brain’s cannabinoid receptors, increasing the risk of altered neural firing.
Association Is Not Causation, But It Demands Caution
Because this was a retrospective observational study at a single medical center, the findings show a strong clinical association, not direct cause-and-effect proof that cannabis causes epilepsy. To get definitive answers, Dr. Struck and Dr. Philibert-Rosas are designing larger, multi-site prospective studies across different regions. These upcoming studies will track precise consumption methods (vaping, edibles, smoking), age of onset, exact THC dosages, and objective blood markers.
Until those larger studies are complete, clinicians advise caution. As Dr. Struck noted, if someone is using unregulated, high-potency cannabis to cope with everyday issues like anxiety or insomnia, it is much safer to treat those symptoms with evidence-based approaches rather than exposing the brain to unregulated compounds with unknown long-term neurological impacts.
Don’t Hide Usage From Healthcare Providers
If you or someone you know experiences unexplained muscle twitching, sudden fainting spells, memory blackouts, or unusual tremors after heavy cannabis use, don’t ignore it. As healthcare teams navigate evolving state medical cannabis laws and clinical guidance, being completely transparent with a doctor or nurse practitioner about how often and how much you consume is essential. Healthcare professionals need the full picture to evaluate what is happening in your brain and protect your overall health